New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis

BACKGROUND: Low-grade gliomas (LGG) are WHO grade II tumors presenting as the most common primary malignant brain tumors in adults. Currently, LGG treatment involves either or a combination of surgery, radiation therapy, and chemotherapy. Despite the knowledge of constitutive genetic risk factors co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Desheng, Yao, Jiawei, Hu, Bowen, Kuang, Liangwen, Xu, Binshun, Liu, Haiyu, Dou, Chao, Wang, Guangzhi, Guo, Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118678/
https://www.ncbi.nlm.nih.gov/pubmed/35585639
http://dx.doi.org/10.1186/s41016-022-00278-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118678/
https://www.ncbi.nlm.nih.gov/pubmed/35585639
http://dx.doi.org/10.1186/s41016-022-00278-0

Ejemplares similares